Experiments that produce unexpected results are often times more informative than predictable experiments. Such is the case for a new…
Maureen Newman
Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment. She is a senior science and research columnist for BioNews Texas.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Maureen Newman
Researchers studying characteristics of cells isolated from muscular dystrophy patients may have found a new target to develop precision medicine.
Messenger RNA (mRNA) and DNA are commonly thought of as the workhorse nucleic acids of a cell. Specialized proteins within…
While groundbreaking discoveries rooted in the laboratory are making progress in treating children with Duchenne muscular dystrophy (DMD), acupuncture and…
To help alleviate the long-term adverse effects of glucocorticoids in patients with Duchenne muscular dystrophy (DMD), a research team at…
Stem cell therapy may be an interesting approach to treat Duchenne muscular dystrophy patients who also have Diamond-Blackfan anemia. A…
Patients with facial paralysis as a result of muscular dystrophy may benefit from new research conducted at Johns Hopkins University…
Muscle wasting in muscular dystrophy may be repairable using a new approach developed by a collaboration among researchers in…